These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8412206)

  • 1. Oltipraz: a laboratory and clinical review.
    Benson AB
    J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
    Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
    Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
    Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
    Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME
    Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
    Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
    Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD
    Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention by inducers of carcinogen detoxication enzymes.
    Kensler TW
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
    Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW
    Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
    Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
    Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of chemoprotection by oltipraz.
    Kensler T; Styczynski P; Groopman J; Helzlsouer K; Curphey T; Maxuitenko Y; Roebuck BD
    J Cell Biochem Suppl; 1992; 16I():167-72. PubMed ID: 1305682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
    Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oltipraz: clinical opportunities for cancer chemoprevention. p.
    Kensler TW; Helzlsouer KJ
    J Cell Biochem Suppl; 1995; 22():101-7. PubMed ID: 8538185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
    Davidson NE; Egner PA; Kensler TW
    Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
    Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
    Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
    Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
    Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
    Scholl P; Musser SM; Kensler TW; Groopman JD
    Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.
    Wang JS; Shen X; He X; Zhu YR; Zhang BC; Wang JB; Qian GS; Kuang SY; Zarba A; Egner PA; Jacobson LP; Muñoz A; Helzlsouer KJ; Groopman JD; Kensler TW
    J Natl Cancer Inst; 1999 Feb; 91(4):347-54. PubMed ID: 10050868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
    Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
    Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemoprotection by oltipraz: experimental and clinical considerations.
    Helzlsouer KJ; Kensler TW
    Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.